Why Obesity May Stack the Deck for COVID-19 Risk

Stephen O’Rahilly, MD, director, MRC Metabolic Diseases Unit, co-director, Wellcome Trust-MRC Institute of Metabolic Science, and director, Wellcome Trust-MRC Institute of Metablic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.

Francis Finucane, MD, consultant endocrinologist, Galway University Hospital, Galway, Ireland.

Carl Lavie, MD, medical director of cardiac rehabilitation and prevention, Ochsner Health, New Orleans.

Med: “When two pandemics meet: Why is obesity associated with increased COVID-19 mortality?”

Nature: “OpenSAFELY: factors associated with COVID-19 death in 17 million patients.”

Mayo Clinic Proceedings: “Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.”

Infectious Diseases of Poverty: “Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.”